SeptemberNew UNC gastrointestinal cancer clinical trials fundedWednesday, September 24, 2008 — The UNC Lineberger Comprehensive Cancer Center has received a two-year, $125,000 grant to support clinical trials in gastrointestinal (GI) cancers. UNC researchers to take part in multi-center, $8.9 million study of childhood hearing lossWednesday, September 24, 2008 — University of North Carolina at Chapel Hill researchers will play a key role in a five-year, $8.9 million study aimed at understanding the impact hearing loss can have on children’s ability to communicate, succeed in school, and have good social and psychological development. UNC radiation oncologist receives national honorSeptember 23, 2008 — Joel E. Tepper, M.D., professor of radiation oncology at the University of North Carolina at Chapel Hill School of Medicine, is being honored by the American Society of Therapeutic Radiology (ASTRO) as one of two recipients of the organization’s Gold Medal Award. UNC scientists turn human skin cells into insulin-producing cellsSeptember 17, 2008 — Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes. UNC study: no need to repeat colonoscopy until 5 years after first screeningSeptember 17, 2008 — Among people who have had an initial colonoscopy that found no polyps, a possible sign of cancer, the risk of developing colorectal cancer within five years is extremely low, a new study has found. UNC researcher receives EUREKA award from NIHSeptember 16, 2008 — Brian D. Strahl, Ph.D., associate professor of biochemistry and biophysics at the University of North Carolina at Chapel Hill School of Medicine, is one of 38 scientists nationally to receive the first grants in a new federal program called EUREKA (Exceptional, Unconventional Research Enabling Knowledge Acceleration). UNC, WPIC to conduct Internet-based study of cognitive behavioral therapy for bulimiaSeptember 15, 2008 — The University of North Carolina at Chapel Hill is leading a novel clinical trial to compare the effectiveness of online cognitive behavioral therapy, delivered through a Web site and augmented with therapist-moderated, weekly online chat sessions, to face-to-face group therapy for the treatment of bulimia nervosa. First generation antipsychotic drugs as effective as newer ones in some childrenSeptember 15, 2008 — Nearly every child who receives an antipsychotic medicine is first prescribed one of the second-generation, or “atypical” drugs, such as olanzapine and risperidone. However, there has never been evidence that these drugs are more effective than the older, first-generation medications. Investment in imaging to accelerate UNC researchers' understanding of diseaseSeptember 11, 2008 — Cancer, Parkinson’s disease, Alzheimer’s, stroke – biomedical researchers at the University of North Carolina at Chapel Hill will be able to make strides in understanding and treating all of these diseases and more because of a $260 million investment to enhance the University’s imaging capabilities. UNC spin-off company receives $2 million grant to market cancer treatment technologySeptember 5, 2008 — A University of North Carolina at Chapel Hill spin-off company has been awarded a $2 million grant to commercialize a new technology to improve radiation treatment of prostate cancer. UNC scientists, research network, unveil results from groundbreaking brain tumor studySeptember 4, 2008 — A nationwide team of scientists, including researchers at the University of North Carolina at Chapel Hill’s Lineberger Comprehensive Cancer Center, have reported the first results of a large-scale, comprehensive study of the most common form of brain cancer, glioblastoma. Laser surgery better than steroid injections for preserving eyesight in diabeticsSeptember 3, 2008 — Newly published results from a clinical trial show that laser surgery is more effective at preserving eyesight in diabetics and has fewer side effects than steroid injections. Nearly half of U.S. adults will develop painful knee osteoarthritis by age 85: studySeptember 2, 2008 — Almost half of all U.S. adults and nearly two-thirds of obese adults will develop painful osteoarthritis of the knee by age 85, a study based at the University of North Carolina at Chapel Hill suggests. Ondansetron reduces vomiting, hospital admissions in children with gastroenteritisSeptember 2, 2008 — University of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis. |
Related institutional links
Loading
